Toll Brothers's long-term debt is $1.7B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest long-term debt for TOL is $1.7B as of July 2026. That compares with $2.9B in the prior-year period — down 40.8% year over year. Investors often review this figure alongside Toll Brothers's historical trend and sector peers before judging valuation or financial health.
Over the past year, TOL's long-term debt moved from $2.9B to $1.7B — a 40.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Toll Brothers's operating scale or balance-sheet position.
A long-term debt figure of $1.7B for TOL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting TOL's long-term debt ($1.7B), review year-over-year change from $2.9B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Toll Brothers's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.